Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis
Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis
Not yet recruiting · NCT07750574 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, anemia, bone marrow disorder, hematologic disorder, primary myelofibrosis | Not yet recruiting | Phase 2 | 2026-08-10 | NCT07750574 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chengdu Zenitar Biomedical Technology Co., Ltd | 15 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||